Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front‐Line Daratumumab Lenalidomide and Dexamethasone
American Journal of Hematology | March 8, 2026 | Volume: 101 | Issue: 4 | Pages: 884-888
10.1002/ajh.70258
| PMID 41738585